Furthermore, Nrf2 another ALR regulating transcription factor [51], was reported to have a pivotal role in development of NAFLD, since Nrf2 attenuates liver steatosis by reducing oxidative stress and inhibiting lipid deposition [46]. Here, GFER is linked to metabolic dysfunction-associated steatotic liver disease.